secwatch / observer
8-K filed February 22, 2023, 6:59 PM ET ticker NPK CIK 0000080172
earnings confidence high sentiment negative materiality 0.75

National Presto Industries 2022 sales $321.6M (-9.6%), EPS $2.92; declares $4.00 dividend; elects new VP Sales

NATIONAL PRESTO INDUSTRIES INC

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

John MacKenzie

Vice President of Sales
NPK · NATIONAL PRESTO INDUSTRIES INC
Effective
2023-02-17
Filed
February 22, 2023, 6:59 PM ET
On February 17, 2023, the registrant announced the election of John MacKenzie to Vice President of Sales.

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 1.0

NATIONAL PRESTO INDUSTRIES INC reported the year ended December 31, 2022 results: revenue $321.6 million, net income $20.7 million, EPS $2.92 per share.

Period
the year ended December 31, 2022
Revenue
$321.6 million
Net income
$20.7 million
EPS
$2.92 per share
Result
reported results
Exact text from the filing
Net 2022 consolidated sales were $321.6 million, down $34.2 million (9.6%) from 2021’s levels. Earnings were $20.7 million ($2.92 per share) a decrease of $5.0 million (19.3%) from 2021’s $25.7 million ($3.63 per share).
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

John MacKenzie was elected as Vice President of Sales at NATIONAL PRESTO INDUSTRIES INC.

Action
elected
Role
Vice President of Sales
Exact text from the filing
On February 17, 2023, the registrant announced the election of John MacKenzie to Vice President of Sales.
View on SEC.gov

Browse all earnings releases →

NATIONAL PRESTO INDUSTRIES INC filing history →

Source: SEC EDGAR
accession 0001437749-23-004165
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.